000			04857cam a2200505Ii 4500
999			_c9536 _d9536
001			9536
003			ES-VaUE
005			20210511171617.0
006			m o d
007			cr cnu---unuuu
008			201031s2021 sz o 001 0 eng d
017			_a1198558432
020			_a9783030520212 ( _q) ( _qelectronic bk.)
020			_a3030520218 ( _q) ( _qelectronic bk.)
020			_z303052020X
020			_z9783030520205
024	7		_a10.1007/978-3-030-52021-2 _2doi
024	1		_aAU@ _b000068175895
040			_aEBLCP _beng _erda _cEBLCP _dYDX _dYDXIT _dOCLCO _dUKAHL _dGW5XE _dOCLCF
050			_aRC280 .T73 2021 EB
082	0	4	_a616.99/46 _223
245	0	0	_aChemotherapy and immunotherapy in urologic oncology : _ba guide for the advanced practice provider _cEdouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi, editors
264		1	_aCham, Switzerland _bSpringer _c2021
300			_a1 online resource
336			_atext _btxt [ _2rdacontent]
337			_acomputer _bc [ _2rdamedia]
338			_aonline resource _bcr [ _2rdacarrier]
500			_aMetastatic Neuroendocrine Carcinoma
500			_aIncludes index
505	0		_aIntro -- Foreword -- Contents -- Contributors -- Chapter 1: Introduction: Integration of APP into Urologic Oncology Practice -- Part I: Prostate Cancer -- Chapter 2: Overview and Active Surveillance of Prostate Cancer -- Introduction -- Epidemiology -- Risk Factors -- Signs and Symptoms -- PSA and Screening -- Diagnostic Evaluation -- Pathology -- Staging -- Risk Stratification -- Active Surveillance -- Bibliography -- Chapter 3: Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Introduction -- Monitoring Categories -- Monitoring for Biochemical Recurrence
505	8		_aRisk Stratification and Additional Testing -- Evidence of Recurrence -- Conclusion -- References -- Chapter 4: Radical Prostatectomy and Survivorship After Radical Prostatectomy -- Radical Prostatectomy -- Survivorship after Radical Prostatectomy -- Urinary Recovery -- Sexual Recovery -- Works Cited -- Chapter 5: Multimodal Treatment Plans in Prostate Cancer -- Introduction -- Postoperative Radiation Therapy -- Genomics -- Bibliography -- Chapter 6: Radiotherapy for Prostate Cancer -- Radiotherapy Techniques -- External Beam Radiation Therapy -- Brachytherapy
505	8		_aRadiation Therapy Based on Prostate Cancer Staging -- Fractionation Schedules and Dosing -- Moderate Hypofractionation -- Ultrahypofractionated Regimens -- Accuracy -- Palliative Radiation Therapy -- Use of Androgen Deprivation Therapy (ADT) with Radiotherapy -- Unfavorable Intermediate-Risk Disease -- High-Risk and Very-High-Risk Disease -- Possible Side Effects -- Unique Toxicities: Recognition, Treatment, and Management -- Fatigue -- Urinary Toxicities -- Gastrointestinal Toxicities -- Sexual Dysfunction -- Stress Fractures -- Methods of Minimizing Adverse Effects
505	8		_aSurvivorship after Radiotherapy -- Urinary Recovery -- Sexual Recovery -- Bowel Toxicity -- Secondary Malignancies -- Other Survivorship Considerations -- Assessing for Recurrence -- Conclusion -- References -- Chapter 7: Androgen Deprivation Therapy -- Introduction -- Mechanism of Action -- Regulation of Androgen Production -- Agents of Treatment -- Removal of Sources of Androgens -- Use of LHRH Agonists and GnRH Antagonists -- Antiandrogens: Nonsteroidal and Steroidal Antiandrogens -- Antiandrogen Withdrawal -- Side Effects Management -- Healthy Lifestyle -- Patient Counseling
505	8		_aSecond-Line Hormone Manipulation -- Ketoconazole -- References -- Chapter 8: Second-Generation Androgen-Targeted Agents -- Second-Generation Androgen-Targeted Agents -- Usage, Indications, and Side Effects of Abiraterone, Enzalutamide, Apalutamide, and Darolutamide -- Abiraterone (ZYTIGA™, YONSA™) -- Enzalutamide (XTANDI™) -- Apalutamide (ERLEADA™) -- Darolutamide (NUBEQA™) -- Conclusion -- References -- Chapter 9: Chemotherapy and Prostate Cancer -- Introduction -- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) -- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
650		0	_aUrinary organs- _xCáncer- _xTreatment
650		7	_aUrinary organs- _xCáncer- _xTreatment.
655		4	_aElectronic books
700	1		_aTrabulsi, Edouard J.
700	1		_aLallas, Costas D.
700	1		_aLizardi-Calvaresi, Anne E.
776	0	8	_iPrint version: _aTrabulsi, Edouard J. _tChemotherapy and Immunotherapy in Urologic Oncology : A Guide for the Advanced Practice Provider, _dCham : Springer International Publishing AG,c2020 _z9783030520205
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-52021-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db